Exchange: NASDAQ·Updated 10:32 PM EDT
SLS logo

SLS SELLAS Life Sciences Group Inc

$13.12
$0.10
(0.76%)
Overnight
Prev Close $13.22
Reported EarningsAug 11
Mkt Cap$2.69B
Vol5.91M

About SLS

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.
53

Neutral Sentiment

How do you feel about SLS?

Advertisement|Remove ads.